Terizidone
{{Drugbox | Verifiedfields = changed | verifiedrevid = 470602455 | IUPAC_name = 4,4′-{1,4-phenylenebis[(E)methylylidenenitrilo]}diisoxazolidin-3-one | image = Terizidone.png | image2 = Terizidone_ball-and-stick.png
| tradename =
| Drugs.com = International Drug Names
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category = C
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =
| CAS_number_Ref = 
| CAS_number = 25683-71-0
| ATC_prefix = J04
| ATC_suffix = AK03
| PubChem = 65720
| DrugBank_Ref = 
| DrugBank =
| ChemSpiderID_Ref =
| ChemSpiderID = 59144
| UNII_Ref =
| UNII = 1199LEX5N8
| KEGG_Ref =
| KEGG = D07247
| C=14 | H=14 | N=4 | O=4
| molecular_weight = 302.286 g/mol
| smiles = O=C3NOCC3/N=C/c2ccc(/C=N/C1C(=O)NOC1)cc2
| InChI = 1/C14H14N4O4/c19-13-11(7-21-17-13)15-5-9-1-2-10(4-3-9)6-16-12-8-22-18-14(12)20/h1-6,11-12H,7-8H2,(H,17,19)(H,18,20)/b15-5+,16-6+
| InChIKey = ODKYYBOHSVLGNU-IAGONARPBB
| StdInChI_Ref =
| StdInChI = 1S/C14H14N4O4/c19-13-11(7-21-17-13)15-5-9-1-2-10(4-3-9)6-16-12-8-22-18-14(12)20/h1-6,11-12H,7-8H2,(H,17,19)(H,18,20)/b15-5+,16-6+
| StdInChIKey_Ref =
| StdInChIKey = ODKYYBOHSVLGNU-IAGONARPSA-N
| synonyms = 4-[({4-[N-(3-oxo-1,2-oxazolidin-4-yl)carboximidoyl]phenyl}methylidene)amino]-1,2-oxazolidin-3-one
}}
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Terizidone is a drug used in the treatment of tuberculosis.
References
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH